Publications by authors named "Charles Debrigode"

Claim this Profile
L
Locoregional relapses in the ACCORD 12/0405-PRODIGE 02 study: Dosimetric study and risk factors.
Nicolas Meillan, Alexandre Orthuon, Paul Chauchat, David Atlani, Olivier Bouche, Charles Debrigode

Radiother Oncol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term follow-up experience in anal canal cancer treated with Intensity-Modulated Radiation Therapy: Clinical outcomes, patterns of relapse and predictors of failure.
Maïlys de Meric de Bellefon, Claire Lemanski, Florence Castan, Emmanuelle Samalin, Thibault Mazard, Charles Debrigode

Radiother Oncol· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of combined use of ArcCheck detector and portal dosimetry for delivery quality assurance of head and neck and prostate volumetric-modulated arc therapy.
Gilles Moliner, Lise Sorro, Rodolfe Verstraet, Paul Alexandre Daviau, Mélanie Casas, Charles Debrigode

J Appl Clin Med Phys· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Radiation therapy-related ataxia associated with FDG-PET cerebellar hypometabolism.
Dimitri Renard, Laurent Collombier, Giovanni Castelnovo, Genevieve Fourcade, Charles Debrigode

Acta Neurol Belg· March 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multicentre phase II study using increasing doses of irinotecan combined with a simplified LV5FU2 regimen in metastatic colorectal cancer.
Jacqueline Duffour, Sophie Gourgou, Françoise Desseigne, Charles Debrigode, Laurent Mineur

Cancer Chemother Pharmacol· August 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updated definition of level VI lymph node classification in the neck.
Benjamin Lallemant, Christophe Reynaud, Caroline Alovisetti, Charles Debrigode, Serge Ovtchinnikoff

Acta Otolaryngol· March 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Individual 5-FU dose adaptation in metastatic colorectal cancer: results of a phase II study using a bimonthly pharmacokinetically intensified LV5FU2 regimen.
Marc Ychou, Jacqueline Duffour, Andrew Kramar, Charles Debrigode, Sophie Gourgou

Cancer Chemother Pharmacol· October 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis